MNPR icon

Monopar Therapeutics

35 hedge funds and large institutions have $109M invested in Monopar Therapeutics in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$3.52M
2 +$2.26M
3 +$2.2M
4
Marshall Wace
Marshall Wace
United Kingdom
+$946K
5
Goldman Sachs
Goldman Sachs
New York
+$673K

Top Sellers

1 -$1.07M
2 -$86.5K
3 -$70.5K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$46.4K
5
TRCT
Tower Research Capital (TRC)
New York
-$14.3K